rmm comparation americas fatima marinho costa rica
TRANSCRIPT
Mortalidad MaternaTendencias y valores
Región de las Américas
Fatima Marinho
Coordinadora Información y Análisis – PAHO
Costa Rica, Feb 2011
ARG. Estimaciones e intervalos IHME
0
10
20
30
40
50
60
70
80
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
CHI. Estimaciones e intervalos IHME
0
10
20
30
40
50
60
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
MEX. Estimaciones e intervalos IHME.
0
10
20
30
40
50
60
70
80
90
100
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
COR. Estimaciones e intervalos IHME.
0
5
10
15
20
25
30
35
40
45
50
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
BOL. Estimaciones e intervalos IHME
0
100
200
300
400
500
600
700
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
ECU. Estimaciones e intervalos IHME.
0
50
100
150
200
250
300
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
HON. Estimaciones e intervalos IHME.
0
50
100
150
200
250
300
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
PAN. Estimaciones e intervalos IHME.
0
10
20
30
40
50
60
70
80
90
100
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
PAR. Estimaciones e intervalos IHME.
0
50
100
150
200
250
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
DOR. Estimaciones e intervalos IHME.
0
50
100
150
200
250
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
VEN. Estimaciones e intervalos IHME.
0
10
20
30
40
50
60
70
80
90
100
IHME
Lower MMR
Upper MMR
PAHO
WHO UNICEF UNFPAWB
Comentarios• The use of the correction factor (CF) of 1.5 and the generalized
application for VR data is problematic.• For those countries with better registration systems (e.g. Canada,
Uruguay, Cuba, Chile) CF causes an artificial increase in MMR and benefits the ones with less quality of vital registration (e g. Guatemala, Belize and Suriname).
• The CF of 1.5 has been applied over 18 years (1990-2008) without any consideration that many countries in this region have improved their vital registration system, especially since 2000. The CF should decrease over time.
• This is the case of Uruguay, Argentina and Mexico. It is very hard to accept the inconsistency between the latest 2005 WHO estimate and the new one, e.g Mexico. In the latter publication, Mexico’s important progress has been started in 2002 and was recognized by WHO while this time it was not considered.
• We expect that the MMR of Argentina, Brazil, Venezuela and Mexico are more proximate.
• We consider the technical note too brief and without enough details to simulate the results.